FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 235 filers reported holding FATE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.88 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $617,000 | -71.4% | 24,918 | -55.3% | 0.00% | -50.0% |
| Q1 2022 | $2,160,000 | -32.5% | 55,724 | +2.3% | 0.00% | 0.0% |
| Q4 2021 | $3,200,000 | +71.3% | 54,469 | +72.8% | 0.00% | +100.0% |
| Q3 2021 | $1,868,000 | -29.2% | 31,524 | +3.7% | 0.00% | -50.0% |
| Q2 2021 | $2,640,000 | -28.3% | 30,413 | -31.9% | 0.00% | -50.0% |
| Q1 2021 | $3,680,000 | -11.3% | 44,644 | -2.1% | 0.00% | 0.0% |
| Q4 2020 | $4,147,000 | +489.9% | 45,608 | +44.0% | 0.00% | +300.0% |
| Q1 2020 | $703,000 | -19.5% | 31,670 | -29.0% | 0.00% | 0.0% |
| Q4 2019 | $873,000 | +28.0% | 44,601 | +1.5% | 0.00% | 0.0% |
| Q3 2019 | $682,000 | -69.1% | 43,947 | -59.5% | 0.00% | -50.0% |
| Q2 2019 | $2,204,000 | +14.5% | 108,566 | -0.9% | 0.00% | 0.0% |
| Q1 2019 | $1,925,000 | +38.5% | 109,549 | +1.1% | 0.00% | 0.0% |
| Q4 2018 | $1,390,000 | -21.1% | 108,361 | +0.2% | 0.00% | 0.0% |
| Q3 2018 | $1,761,000 | +5580.6% | 108,132 | +492.4% | 0.00% | – |
| Q2 2016 | $31,000 | -91.3% | 18,252 | -90.8% | 0.00% | – |
| Q1 2016 | $355,000 | -49.6% | 197,329 | -5.7% | 0.00% | -100.0% |
| Q4 2015 | $705,000 | -31.4% | 209,307 | +8.7% | 0.00% | 0.0% |
| Q3 2015 | $1,027,000 | – | 192,596 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 569,889 | $51,820,000 | 67.63% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,379,064 | $307,258,000 | 39.62% |
| Darwin Global Management, Ltd. | 952,847 | $86,642,000 | 24.18% |
| Redmile Group, LLC | 12,629,737 | $1,148,422,000 | 13.91% |
| DAFNA Capital Management LLC | 334,360 | $30,403,000 | 9.05% |
| Casdin Capital, LLC | 3,050,000 | $277,337,000 | 8.22% |
| Grosvenor Holdings, L.L.C. | 1,459,517 | $132,714,000 | 7.23% |
| Copernicus Capital Management, LLC | 3,240 | $295,000 | 4.60% |
| Eversept Partners, LP | 399,499 | $36,326,444 | 4.26% |
| Ally Bridge Group (NY) LLC | 260,000 | $23,642,000 | 4.05% |